Related Experiment Video

Updated: Jun 23, 2026

Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement
10:45

Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement

Published on: July 26, 2017

Myostatin in the pathophysiology of skeletal muscle

Gilles Carnac1, Barbara Vernus, Anne Bonnieu

  • 1INSERM, ERI 25-Muscle et Pathologies, Hôpital Arnaud de Villeneuve, Bât. A Craste de Paulet, 34295 Montpellier Cedex 5, France.

Current Genomics
|May 5, 2009
PubMed

Insights

Myostatin negatively regulates muscle growth. Inhibiting the myostatin pathway shows promise for treating muscle wasting disorders by affecting muscle fiber size and number.

Area of Science:

  • Muscle Biology
  • Molecular Medicine
  • Regenerative Medicine

Background:

  • Myostatin is a key negative regulator of skeletal muscle mass.
  • The myostatin pathway's role in muscle growth, regeneration, and catabolism is conserved across species.
  • Inhibition of myostatin is a potential therapeutic strategy for muscle wasting conditions.

Purpose of the Study:

  • To review recent advancements in myostatin research.
  • To explore the molecular and cellular mechanisms of myostatin action in skeletal muscle.
  • To discuss the therapeutic potential of targeting the myostatin pathway for muscle disorders.

Main Methods:

  • Literature review of experimental models and clinical studies.
  • Analysis of molecular and cellular pathways regulated by myostatin.
  • Discussion of current controversies and future directions in myostatin research.

Main Results:

  • Myostatin critically influences muscle fiber number and size.
  • The myostatin pathway is implicated in muscle catabolism and regeneration processes.
  • Evidence suggests myostatin inhibition can counteract muscle wasting.

Conclusions:

  • Myostatin is a crucial target for understanding and treating muscle-related disorders.
  • Further research into myostatin's mechanisms and therapeutic applications is warranted.
  • Targeting the myostatin pathway holds significant promise for regenerative medicine and combating muscle atrophy.

More Related Videos

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model06:33

Freezing Injury in Mouse Masseter Muscle to Establish an Orofacial Muscle Fibrosis Model

Published on: December 29, 2023

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Actin and Myosin in Muscle Contraction01:16

Actin and Myosin in Muscle Contraction

Actin and myosin are contractile proteins that form the sarcomere found in skeletal muscle tissues for regulating muscle contraction. Actin, a globular contractile protein, interacts with myosin for muscle contraction. The skeletal tissue appears striped or striated under a microscope due to the repeated arrangement of contractile proteins actin and myosin along the length of myofibrils. Dark A bands and light I bands repeat along myofibrils, and the alignment of myofibrils in the cell causes...